MEAD, G.E.,
LEGG, L.,
TILNEY, R.,
HSIEH, C.F.,
WU, S.,
LUNDSTRÖM, E.,
RUDBERG, A.S.,
KUTLUBAEV, M.,
DENNIS, M.S.,
SOLEIMANI, B.,
BARUGH, A.,
HACKETT, M.L.,
HANKEY, G.J. (2020) ,
neurological deficits and fatigue; improved motor function, mood, and cognition at the end of treatment
Shnayder, Natalia A.,
Grechkina, Violetta V.,
Trefilova, Vera V.,
Efremov, Ilya S.,
Dontceva, Evgenia A.,
Narodova, Ekaterina A.,
Petrova, Marina M.,
Soloveva, Irina A.,
Tepnadze, Liia E.,
Reznichenko, Polina A.,
Al-Zamil, Mustafa,
Altynbekova, Gulnara I.,
Strelnik, Anna I.,
Nasyrova, Regina F. (2023) that are widely used in
neurology and psychiatry. The long-term use of VPA increases the risk of developing
. All patients underwent
neurological examinations (
neurological status, magnetic resonance imaging